The effect of cholesterol-lowering treatment on renal function.
Evagelos N
EN
Liberopoulos
Dimitri P
DP
Mikhailidis
Vasilios G
VG
Athyros
Moses S
MS
Elisaf
D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology
D000924:Anticholesteremic Agents; D002792:Cholestyramine Resin